UKGrowth Network

UK company record

Exscientia

AI drug discovery

ReviewCore UK
Open interactive recordCompanies House profile

Snapshot

UK location
Oxford · South East
Sector
Biotech & techbio
Latest recorded round
Series D
Latest recorded amount
$225M equity (plus up to $300M SoftBank commitment; up to $525M total)
Date
2021-04-01

Legal-identity layer

Review identity.

Selected legal name
EXSCIENTIA LIMITED
Company number
13483814
Companies House status
active
Incorporated
2021-06-29

Investors

Current directors and active controllers

  • NELSON, Kyle BenjaminCurrent director
  • OVERTON, Andrew JohnCurrent director
  • Recursion Pharmaceuticals, Inc.Active controller
  • TAYLOR, Ben RobertsCurrent director
  • TAYLOR, Ben RobertsCurrent director
  • Andrew Lee HopkinsFormer controller
  • CRAIN, Elizabeth Ann, Ms.director
  • GHENCHEV, Robert Evgenievdirector
  • GIBSON, Christopherdirector
  • HALLETT, David Jamesdirector
  • HATFIELD, Nathansecretary
  • HATFIELD, Nathan Bendirector
  • HOPKINS, Andrew Leedirector
  • IRELAND, Danielsecretary
  • MICHOR, Franziskadirector
  • NICHOLSON, David Charlesdirector
  • POLYWKA, Mario Eugenio Cosiminodirector
  • XU, Juan, Mr.director

Funding rows

Sources